{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T20:37:49Z","timestamp":1792787869901,"version":"4.5.0"},"reference-count":49,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2021,12,18]],"date-time":"2021-12-18T00:00:00Z","timestamp":1639785600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2021,12,18]],"date-time":"2021-12-18T00:00:00Z","timestamp":1639785600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"Key Technology Research and Development Program of China","award":["2017YFC1310902"],"award-info":[{"award-number":["2017YFC1310902"]}]},{"name":"Key Technology Research and Development Program of China","award":["2018YFC1315305"],"award-info":[{"award-number":["2018YFC1315305"]}]},{"name":"Ningbo Health Branding Subject Fund","award":["PPXK2018-02"],"award-info":[{"award-number":["PPXK2018-02"]}]},{"name":"Sanming Project of Medicine in Shen-zhen","award":["SZSM201803080"],"award-info":[{"award-number":["SZSM201803080"]}]},{"DOI":"10.13039\/501100012456","name":"National Social Science Foundation of China","doi-asserted-by":"crossref","award":["19AZD013)"],"award-info":[{"award-number":["19AZD013)"]}],"id":[{"id":"10.13039\/501100012456","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100012456","name":"National Social Science Foundation of China","doi-asserted-by":"crossref","award":["National Natural Science Foundation of China (72004104). The funder had no role in the study desig"],"award-info":[{"award-number":["National Natural Science Foundation of China (72004104). The funder had no role in the study desig"]}],"id":[{"id":"10.13039\/501100012456","id-type":"DOI","asserted-by":"crossref"}]},{"name":"the Innovative Talent Support Plan of the Medical and Health Technology Project in Zhejiang Province","award":["2021422878"],"award-info":[{"award-number":["2021422878"]}]},{"name":"Ningbo Science and Technology Project","award":["202002N3152"],"award-info":[{"award-number":["202002N3152"]}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["72004104"],"award-info":[{"award-number":["72004104"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Women's Health"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Cervical cancer is one of the most common cancers among women worldwide. The formulation or evaluation on prevention strategies all require an accurate understanding of the burden for cervical cancer burden. We aimed to report the up-to-date estimates of cervical cancer burden at global, regional, and national levels.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>Data were extracted from the Global Burden of Diseases, Injuries, and Risk Factors Study (GBD) 2017 study. The counts, age-standardized rates, and percentage changes of incidence, disability-adjusted life-years (DALYs), and death attributed to cervical cancer at the global, regional, and national levels in all 195 countries and territories from 21 regions during 2007 to 2017 by age and by Socio-demographic Index (SDI) were measured. All estimates were reported with 95% uncertainty intervals (UIs).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>In 2017, 601,186 (95% UI 554,455 to 625,402) incident cases of cervical cancer were reported worldwide, which caused 8,061,667 (7,527,014 to 8,401,647) DALYs and 259,671 (241,128 to 269,214) deaths. The age-standardized rates for incidence, DALYs and death decreased by\u2009\u2212\u20092.8% (\u2212\u20097.8% to 0.6%),\u2009\u2212\u20097.1% [\u2212\u200911.8% to\u2009\u2212\u20093.9%] and\u2009\u2212\u20096.9% [\u2212\u200911.5% to\u2009\u2212\u20093.7%] from 2007 to 2017, respectively. The highest age-standardized incidence, DALYs and death rates in 2017 were observed in the low SDI quintile, Oceania, Central and Eastern Sub-Saharan Africa. During 2007 to 2017, only East Asia showed increase in these rates despite not significant. At the national level, the highest age-standardized rates for incidence, DALYs, and death in 2017 were observed in Kiribati, Somalia, Eritrea, and Central African Republic; and Georgia showed the largest increases in all these rates during 2007 to 2017.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>Although the age-standardized rates for incidence, DALYs, and death of cervical cancer have decreased in most parts of the world from 2007 to 2017, cervical cancer remains a major public health concern in view of the absolute number of cervical cancer cases, DALYs, and deaths increased during this period. The challenge is more prone to in the low SDI quintile, Oceania, Central and Eastern Sub-Saharan Africa, East Asia, and some countries, suggesting an urgent to promote human papillomavirus vaccination in these regions.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s12905-021-01571-3","type":"journal-article","created":{"date-parts":[[2021,12,18]],"date-time":"2021-12-18T03:02:16Z","timestamp":1639796536000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":41,"title":["Global, regional, and national burden of cervical cancer for 195 countries and territories, 2007\u20132017: findings from the Global Burden of Disease Study 2017"],"prefix":"10.1186","volume":"21","author":[{"given":"Miaomiao","family":"Zhao","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qunhong","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yanhua","family":"Hao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jingcen","family":"Hu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuexia","family":"Gao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shan","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liyuan","family":"Han","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,12,18]]},"reference":[{"issue":"6","key":"1571_CR1","doi-asserted-by":"publisher","first-page":"394","DOI":"10.3322\/caac.21492","volume":"68","author":"F Bray","year":"2018","unstructured":"Bray F, Ferlay J, Soerjomataram I, Siegel RL, Torre LA, Jemal A. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2018;68(6):394\u2013424.","journal-title":"CA Cancer J Clin"},{"key":"1571_CR2","volume-title":"Draft: global strategy towards eliminating cervical cancer as a public health problem","author":"WHO","year":"2020","unstructured":"WHO. Draft: global strategy towards eliminating cervical cancer as a public health problem. WHO; 2020."},{"issue":"4","key":"1571_CR3","doi-asserted-by":"publisher","first-page":"244","DOI":"10.1136\/jcp.55.4.244","volume":"55","author":"FX Bosch","year":"2002","unstructured":"Bosch FX, Lorincz A, Munoz N, Meijer CJ, Shah KV. The causal relation between human papillomavirus and cervical cancer. J Clin Pathol. 2002;55(4):244\u201365.","journal-title":"J Clin Pathol"},{"issue":"2","key":"1571_CR4","first-page":"F55","volume":"1288","author":"HH Zur","year":"1996","unstructured":"Zur HH. Papillomavirus infections\u2014a major cause of human cancers. Biochim Biophys Acta. 1996;1288(2):F55\u201378.","journal-title":"Biochim Biophys Acta"},{"issue":"2","key":"1571_CR5","doi-asserted-by":"publisher","first-page":"278","DOI":"10.1002\/ijc.20244","volume":"111","author":"N Mu\u00f1oz","year":"2004","unstructured":"Mu\u00f1oz N, Bosch FX, Castellsagu\u00e9 X, D\u00edaz M, de Sanjose S, Hammouda D, Shah KV, Meijer CJLM. Against which human papillomavirus types shall we vaccinate and screen? The international perspective. Int J Cancer. 2004;111(2):278\u201385.","journal-title":"Int J Cancer"},{"issue":"7","key":"1571_CR6","doi-asserted-by":"publisher","first-page":"e453","DOI":"10.1016\/S2214-109X(16)30099-7","volume":"4","author":"L Bruni","year":"2016","unstructured":"Bruni L, Diaz M, Barrionuevo-Rosas L, Herrero R, Bray F, Bosch FX, de Sanjos\u00e9 S, Castellsagu\u00e9 X. Global estimates of human papillomavirus vaccination coverage by region and income level: a pooled analysis. Lancet Glob Health. 2016;4(7):e453\u201363.","journal-title":"Lancet Glob Health"},{"key":"1571_CR7","unstructured":"WHO. WHO Director-General calls for all countries to take action to help end the suffering caused by cervical cancer."},{"issue":"2","key":"1571_CR8","first-page":"319","volume":"19","author":"AD Shrestha","year":"2018","unstructured":"Shrestha AD, Neupane D, Vedsted P, Kallestrup P. Cervical cancer prevalence, incidence and mortality in low and middle income countries: a systematic review. Asian Pacif J Cancer Prevent. 2018;19(2):319\u201324.","journal-title":"Asian Pacif J Cancer Prevent"},{"issue":"S10","key":"1571_CR9","first-page":"2955","volume":"113","author":"JH Bates","year":"2008","unstructured":"Bates JH, Hofer BM, Parikh-Patel A. Cervical cancer incidence, mortality, and survival among Asian subgroups in California, 1990\u20132004. Cancer Am Cancer Soc. 2008;113(S10):2955\u201363.","journal-title":"Cancer Am Cancer Soc"},{"issue":"2","key":"1571_CR10","doi-asserted-by":"publisher","first-page":"e191","DOI":"10.1016\/S2214-109X(19)30482-6","volume":"8","author":"M Arbyn","year":"2020","unstructured":"Arbyn M, Weiderpass E, Bruni L, de Sanjos\u00e9 S, Saraiya M, Ferlay J, Bray F. Estimates of incidence and mortality of cervical cancer in 2018: a worldwide analysis. Lancet Glob Health. 2020;8(2):e191\u2013203.","journal-title":"Lancet Glob Health"},{"issue":"10159","key":"1571_CR11","doi-asserted-by":"publisher","first-page":"1859","DOI":"10.1016\/S0140-6736(18)32335-3","volume":"392","author":"HH Kyu","year":"2018","unstructured":"Kyu HH, Abate D, Abate KH, Abay SM, Abbafati C, Abbasi N, Abbastabar H, Abd-Allah F, Abdela J, Abdelalim A, Abdollahpour I. Global, regional, and national disability-adjusted life-years (DALYs) for 359 diseases and injuries and healthy life expectancy (HALE) for 195 countries and territories, 1990\u20132017: a systematic analysis for the Global Burden of Disease Study 2017. Lancet. 2018;392(10159):1859\u2013922.","journal-title":"Lancet"},{"issue":"10159","key":"1571_CR12","doi-asserted-by":"publisher","first-page":"1789","DOI":"10.1016\/S0140-6736(18)32279-7","volume":"392","author":"SL James","year":"2018","unstructured":"James SL, Abate D, Abate KH, Abay SM, Abbafati C, Abbasi N, Abbastabar H, Abd-Allah F, Abdela J, Abdelalim A, Abdollahpour I. Global, regional, and national incidence, prevalence, and years lived with disability for 354 diseases and injuries for 195 countries and territories, 1990\u20132017: a systematic analysis for the Global Burden of Disease Study 2017. Lancet. 2018;392(10159):1789\u2013858.","journal-title":"Lancet"},{"issue":"10159","key":"1571_CR13","doi-asserted-by":"publisher","first-page":"1736","DOI":"10.1016\/S0140-6736(18)32203-7","volume":"392","author":"GA Roth","year":"2018","unstructured":"Roth GA, Abate D, Abate KH, Abay SM, Abbafati C, Abbasi N, Abbastabar H, Abd-Allah F, Abdela J, Abdelalim A, Abdollahpour I. Global, regional, and national age-sex-specific mortality for 282 causes of death in 195 countries and territories, 1980\u20132017: a systematic analysis for the Global Burden of Disease Study 2017. Lancet. 2018;392(10159):1736\u201388.","journal-title":"Lancet"},{"issue":"10159","key":"1571_CR14","doi-asserted-by":"publisher","first-page":"1684","DOI":"10.1016\/S0140-6736(18)31891-9","volume":"392","author":"D Dicker","year":"2018","unstructured":"Dicker D, Nguyen G, Abate D, Abate KH, Abay SM, Abbafati C, Abbasi N, Abbastabar H, Abd-Allah F, Abdela J, Abdelalim A. Global, regional, and national age-sex-specific mortality and life expectancy, 1950\u20132017: a systematic analysis for the Global Burden of Disease Study 2017. Lancet. 2018;392(10159):1684\u2013735.","journal-title":"Lancet"},{"issue":"12","key":"1571_CR15","doi-asserted-by":"publisher","first-page":"1749","DOI":"10.1001\/jamaoncol.2019.2996","volume":"5","author":"C Fitzmaurice","year":"2019","unstructured":"Fitzmaurice C, Abate D, Abbasi N, Abbastabar H, Abd-Allah F, Abdel-Rahman O, Abdelalim A, Abdoli A, Abdollahpour I, Abdulle A, et al. Global, regional, and national cancer incidence, mortality, years of life lost, years lived with disability, and disability-adjusted life-years for 29 cancer groups, 1990 to 2017: a systematic analysis for the global burden of disease study. JAMA Oncol. 2019;5(12):1749\u201368.","journal-title":"JAMA Oncol"},{"key":"1571_CR16","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1016\/S2468-1253(19)30328-0","volume":"5","author":"A Etemadi","year":"2019","unstructured":"Etemadi A, Safiri S, Sepanlou SG, Ikuta K, Bisignano C, Shakeri R, Amani M, Fitzmaurice C, Nixon M, Abbasi N, et al. The global, regional, and national burden of stomach cancer in 195 countries, 1990\u20132017: a systematic analysis for the Global Burden of Disease study 2017. Lancet Gastroenterol Hepatol. 2019;5:42\u201354.","journal-title":"Lancet Gastroenterol Hepatol"},{"key":"1571_CR17","doi-asserted-by":"publisher","first-page":"934","DOI":"10.1016\/S2468-1253(19)30347-4","volume":"4","author":"A Pourshams","year":"2019","unstructured":"Pourshams A, Sepanlou SG, Ikuta KS, Bisignano C, Safiri S, Roshandel G, Sharif M, Khatibian M, Fitzmaurice C, Nixon MR, et al. The global, regional, and national burden of pancreatic cancer and its attributable risk factors in 195 countries and territories, 1990\u20132017: a systematic analysis for the Global Burden of Disease Study 2017. Lancet Gastroenterol Hepatol. 2019;4:934\u201347.","journal-title":"Lancet Gastroenterol Hepatol"},{"issue":"12","key":"1571_CR18","doi-asserted-by":"publisher","first-page":"2675","DOI":"10.1093\/annonc\/mdr015","volume":"22","author":"M Arbyn","year":"2011","unstructured":"Arbyn M, Castellsague X, de Sanjose S, Bruni L, Saraiya M, Bray F, Ferlay J. Worldwide burden of cervical cancer in 2008. ANN ONCOL. 2011;22(12):2675\u201386.","journal-title":"ANN ONCOL"},{"key":"1571_CR19","unstructured":"IARC Handbooks of Cancer Prevention. Volume 10.Cervix Cancer Screening; 2005."},{"issue":"10197","key":"1571_CR20","doi-asserted-by":"publisher","first-page":"497","DOI":"10.1016\/S0140-6736(19)30298-3","volume":"394","author":"M Drolet","year":"2019","unstructured":"Drolet M, B\u00e9nard \u00c9, P\u00e9rez N, Brisson M, Ali H, Boily M, Baldo V, Brassard P, Brotherton JML, Callander D, et al. Population-level impact and herd effects following the introduction of human papillomavirus vaccination programmes: updated systematic review and meta-analysis. Lancet. 2019;394(10197):497\u2013509.","journal-title":"Lancet"},{"key":"1571_CR21","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1016\/j.ejca.2019.12.013","volume":"127","author":"EEL Jansen","year":"2020","unstructured":"Jansen EEL, Zielonke N, Gini A, Anttila A, Segnan N, Vok\u00f3 Z, Ivanu\u0161 U, McKee M, de Koning HJ, de Kok IMCM, et al. Effect of organised cervical cancer screening on cervical cancer mortality in Europe: a systematic review. Eur J Cancer. 2020;127:207\u201323.","journal-title":"Eur J Cancer"},{"issue":"15","key":"1571_CR22","doi-asserted-by":"publisher","first-page":"3262","DOI":"10.1016\/j.ejca.2013.04.024","volume":"49","author":"S Vaccarella","year":"2013","unstructured":"Vaccarella S, Lortet-Tieulent J, Plummer M, Franceschi S, Bray F. Worldwide trends in cervical cancer incidence: impact of screening against changes in disease risk factors. EUR J Cancer. 2013;49(15):3262\u201373.","journal-title":"EUR J Cancer"},{"key":"1571_CR23","first-page":"10","volume":"4","author":"RA Manaf","year":"2017","unstructured":"Manaf RA, Ismail S, Cecilia NC. Global burden of cervical cancer: a literature review. Int J Public Health Clin Sci. 2017;4:10\u20138.","journal-title":"Int J Public Health Clin Sci"},{"issue":"10","key":"1571_CR24","first-page":"954","volume":"79","author":"R Sankaranarayanan","year":"2001","unstructured":"Sankaranarayanan R, Budukh AM, Rajkumar R. Effective screening programmes for cervical cancer in low- and middle-income developing countries. Bull World Health Organ. 2001;79(10):954\u201362.","journal-title":"Bull World Health Organ"},{"issue":"6","key":"1571_CR25","doi-asserted-by":"publisher","first-page":"e132","DOI":"10.1371\/journal.pmed.0050132","volume":"5","author":"E Gakidou","year":"2008","unstructured":"Gakidou E, Nordhagen S, Obermeyer Z. Coverage of cervical cancer screening in 57 countries: low average levels and large inequalities. PLOS Med. 2008;5(6):e132.","journal-title":"PLOS Med"},{"key":"1571_CR26","unstructured":"Bruni L, Albero G, Serrano B, Mena M, G\u00f3mez D, Mu\u00f1oz J, Bosch F, de Sanjos\u00e9 S: ICO\/IARC information centre on HPV and cancer (HPV information centre). Human papillomavirus and related diseases in Oceania. Summary report 17 June 2019."},{"issue":"21","key":"1571_CR27","doi-asserted-by":"publisher","first-page":"9433","DOI":"10.7314\/APJCP.2014.15.21.9433","volume":"15","author":"J Obel","year":"2014","unstructured":"Obel J, Souares Y, Hoy D, Baravilala W, Garland SM, Kjaer SK, Roth A. A systematic review of cervical cancer incidence and mortality in the Pacific region. Asian Pac J Cancer Prev. 2014;15(21):9433\u20137.","journal-title":"Asian Pac J Cancer Prev"},{"issue":"8","key":"1571_CR28","doi-asserted-by":"publisher","first-page":"3435","DOI":"10.7314\/APJCP.2015.16.8.3435","volume":"16","author":"J Obel","year":"2015","unstructured":"Obel J, McKenzie J, Buenconsejo-Lum LE, Durand AM, Ekeroma A, Souares Y, Hoy D, Baravilala W, Garland SM, Kjaer SK, et al. Mapping HPV vaccination and cervical cancer screening practice in the Pacific region-strengthening national and regional cervical cancer prevention. Asian Pac J Cancer Prev. 2015;16(8):3435\u201342.","journal-title":"Asian Pac J Cancer Prev"},{"issue":"12","key":"1571_CR29","doi-asserted-by":"publisher","first-page":"1789","DOI":"10.1086\/657321","volume":"202","author":"L Bruni","year":"2010","unstructured":"Bruni L, Diaz M, Castellsagu\u00e9 X, Ferrer E, Bosch FX, de Sanjos\u00e9 S. Cervical human papillomavirus prevalence in 5 continents: meta-analysis of 1 million women with normal cytological findings. J Infect Dis. 2010;202(12):1789\u201399.","journal-title":"J Infect Dis"},{"issue":"Suppl 5","key":"1571_CR30","doi-asserted-by":"publisher","first-page":"F32","DOI":"10.1016\/j.vaccine.2012.07.092","volume":"31","author":"H De Vuyst","year":"2013","unstructured":"De Vuyst H, Alemany L, Lacey C, Chibwesha CJ, Sahasrabuddhe V, Banura C, Denny L, Parham GP. The burden of human papillomavirus infections and related diseases in sub-saharan Africa. Vaccine. 2013;31(Suppl 5):F32\u201346.","journal-title":"Vaccine"},{"issue":"1","key":"1571_CR31","doi-asserted-by":"publisher","first-page":"e2231","DOI":"10.1136\/bmjgh-2019-002231","volume":"5","author":"DY Melesse","year":"2020","unstructured":"Melesse DY, Mutua MK, Choudhury A, Wado YD, Faye CM, Neal S, Boerma T. Adolescent sexual and reproductive health in sub-Saharan Africa: who is left behind? BMJ Glob Health. 2020;5(1):e2231.","journal-title":"BMJ Glob Health"},{"issue":"10","key":"1571_CR32","doi-asserted-by":"publisher","first-page":"1287","DOI":"10.1111\/j.1365-3156.2009.02372.x","volume":"14","author":"KS Louie","year":"2009","unstructured":"Louie KS, de Sanjose S, Mayaud P. Epidemiology and prevention of human papillomavirus and cervical cancer in sub-Saharan Africa: a comprehensive review. Trop Med Int Health. 2009;14(10):1287\u2013302.","journal-title":"Trop Med Int Health"},{"issue":"7","key":"1571_CR33","doi-asserted-by":"publisher","first-page":"796","DOI":"10.1111\/j.1365-3156.2012.03005.x","volume":"17","author":"AM Doyle","year":"2012","unstructured":"Doyle AM, Mavedzenge SN, Plummer ML, Ross DA. The sexual behaviour of adolescents in sub-Saharan Africa: patterns and trends from national surveys. Trop Med Int Health. 2012;17(7):796\u2013807.","journal-title":"Trop Med Int Health"},{"issue":"3","key":"1571_CR34","doi-asserted-by":"publisher","first-page":"332","DOI":"10.1097\/QAI.0000000000001113","volume":"73","author":"GM Clifford","year":"2016","unstructured":"Clifford GM, de Vuyst H, Tenet V, Plummer M, Tully S, Franceschi S. Effect of HIV infection on human papillomavirus types causing invasive cervical cancer in Africa. J Acquir Immune Defic Syndr. 2016;73(3):332\u20139.","journal-title":"J Acquir Immune Defic Syndr"},{"issue":"1","key":"1571_CR35","first-page":"e8533","volume":"6","author":"MF Isa","year":"2016","unstructured":"Isa MF, Dareng E, Bamisaye P, Jedy-Agba E, Adewole A, Oyeneyin L, Olaniyan O, Adebamowo C. Qualitative study of barriers to cervical cancer screening among Nigerian women. BMJ Open. 2016;6(1):e8533.","journal-title":"BMJ Open"},{"issue":"3","key":"1571_CR36","doi-asserted-by":"publisher","first-page":"e90912","DOI":"10.1371\/journal.pone.0090912","volume":"9","author":"S Perlman","year":"2014","unstructured":"Perlman S, Wamai RG, Bain PA, Welty T, Welty E, Ogembo JG. Knowledge and awareness of HPV vaccine and acceptability to vaccinate in sub-Saharan Africa: a systematic review. PLoS ONE. 2014;9(3):e90912.","journal-title":"PLoS ONE"},{"key":"1571_CR37","doi-asserted-by":"publisher","first-page":"1304","DOI":"10.1016\/j.jiph.2020.06.012","volume":"13","author":"DA Obeid","year":"2020","unstructured":"Obeid DA, Almatrrouk SA, Alfageeh MB, Al-Ahdal MNA, Alhamlan FS. Human papillomavirus epidemiology in populations with normal or abnormal cervical cytology or cervical cancer in the Middle East and North Africa: a systematic review and meta-analysis. J Infect Public Health. 2020;13:1304\u201313.","journal-title":"J Infect Public Health"},{"key":"1571_CR38","doi-asserted-by":"publisher","first-page":"G51","DOI":"10.1016\/j.vaccine.2012.06.046","volume":"31","author":"H Sancho-Garnier","year":"2013","unstructured":"Sancho-Garnier H, Khazraji YC, Cherif MH, Mahnane A, Hsairi M, Shalakamy AE, Osgul N, Tuncer M, Jumaan AO, Seoud M. Overview of cervical cancer screening practices in the extended middle east and north Africa countries. Vaccine. 2013;31:G51\u20137.","journal-title":"Vaccine"},{"issue":"4","key":"1571_CR39","doi-asserted-by":"publisher","first-page":"384","DOI":"10.1016\/j.canep.2012.01.009","volume":"36","author":"F Zhao","year":"2012","unstructured":"Zhao F, Tiggelaar SM, Hu S, Xu L, Hong Y, Niyazi M, Gao X, Ju L, Zhang L, Feng X, et al. A multi-center survey of age of sexual debut and sexual behavior in Chinese women: suggestions for optimal age of human papillomavirus vaccination in China. Cancer Epidemiol. 2012;36(4):384\u201390.","journal-title":"Cancer Epidemiol"},{"issue":"3","key":"1571_CR40","doi-asserted-by":"publisher","first-page":"641","DOI":"10.1002\/ijc.26042","volume":"130","author":"JF Shi","year":"2012","unstructured":"Shi JF, Canfell K, Lew JB, Qiao YL. The burden of cervical cancer in China: synthesis of the evidence. Int J Cancer. 2012;130(3):641\u201352.","journal-title":"Int J Cancer"},{"issue":"12","key":"1571_CR41","doi-asserted-by":"publisher","first-page":"1322","DOI":"10.1016\/S1473-3099(16)30450-9","volume":"16","author":"X Pan","year":"2016","unstructured":"Pan X, Li R, Pan A, Larson H. Human papillomavirus vaccine approval in China: a major step forward but challenges ahead. Lancet Infect Dis. 2016;16(12):1322\u20133.","journal-title":"Lancet Infect Dis"},{"issue":"10104","key":"1571_CR42","doi-asserted-by":"publisher","first-page":"1735","DOI":"10.1016\/S0140-6736(17)32606-5","volume":"390","author":"Y Yin","year":"2017","unstructured":"Yin Y. HPV vaccination in China needs to be more cost-effective. Lancet. 2017;390(10104):1735\u20136.","journal-title":"Lancet"},{"issue":"4","key":"1571_CR43","first-page":"502","volume":"122","author":"BL Bychkovsky","year":"2016","unstructured":"Bychkovsky BL, Ferreyra ME, Strasser-Weippl K, Herold CI, de Lima LGJ, Dizon DS, Schmeler KM, Del CM, Randall TC, Nogueira-Rodrigues A, et al. Cervical cancer control in Latin America: a call to action. Cancer Am Cancer Soc. 2016;122(4):502\u201314.","journal-title":"Cancer Am Cancer Soc"},{"issue":"1","key":"1571_CR44","doi-asserted-by":"publisher","first-page":"53","DOI":"10.3390\/ijerph13010053","volume":"13","author":"E Coronado Interis","year":"2015","unstructured":"Coronado Interis E, Anakwenze C, Aung M, Jolly P. Increasing cervical cancer awareness and screening in Jamaica: effectiveness of a theory-based educational intervention. Int J Environ Res Public Health. 2015;13(1):53.","journal-title":"Int J Environ Res Public Health"},{"key":"1571_CR45","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1177\/0969141320902482","volume":"28","author":"G Aimagambetova","year":"2020","unstructured":"Aimagambetova G, Chan CK, Ukybassova T, Imankulova B, Balykov A, Kongrtay K, Azizan A. Cervical cancer screening and prevention in Kazakhstan and Central Asia. J Med Screen. 2020;28:48\u201350.","journal-title":"J Med Screen"},{"issue":"3","key":"1571_CR46","doi-asserted-by":"publisher","first-page":"142","DOI":"10.1258\/0969141054855328","volume":"12","author":"LO Sarian","year":"2005","unstructured":"Sarian LO, Derchain SF, Naud P, Roteli-Martins C, Longatto-Filho A, Tatti S, Branca M, Erzen M, Serpa-Hammes L, Matos J, et al. Evaluation of visual inspection with acetic acid (VIA), Lugol\u2019s iodine (VILI), cervical cytology and HPV testing as cervical screening tools in Latin America. This report refers to partial results from the LAMS (Latin AMerican Screening) study. J Med Screen. 2005;12(3):142\u20139.","journal-title":"J Med Screen"},{"issue":"5","key":"1571_CR47","doi-asserted-by":"publisher","first-page":"465","DOI":"10.1016\/j.canep.2010.12.006","volume":"35","author":"T Alibegashvili","year":"2010","unstructured":"Alibegashvili T, Clifford GM, Vaccarella S, Baidoshvili A, Gogiashvili L, Tsagareli Z, Kureli I, Snijders PJF, Heideman DAM, van Kemenade FJ, et al. Human papillomavirus infection in women with and without cervical cancer in Tbilisi, Georgia. Cancer Epidemiol. 2010;35(5):465\u201370.","journal-title":"Cancer Epidemiol"},{"issue":"6","key":"1571_CR48","doi-asserted-by":"publisher","first-page":"437","DOI":"10.1097\/00130404-200511000-00002","volume":"11","author":"R Yancik","year":"2005","unstructured":"Yancik R. Population aging and cancer: a cross-national concern. Cancer J. 2005;11(6):437\u201341.","journal-title":"Cancer J"},{"issue":"12","key":"1571_CR49","doi-asserted-by":"publisher","first-page":"913","DOI":"10.1016\/S2468-1253(19)30345-0","volume":"4","author":"S Safiri","year":"2019","unstructured":"Safiri S, Sepanlou SG, Ikuta KS, Bisignano C, Salimzadeh H, Delavari A, Ansari R, Roshandel G, Merat S, Fitzmaurice C, et al. The global, regional, and national burden of colorectal cancer and its attributable risk factors in 195 countries and territories, 1990\u20132017: a systematic analysis for the Global Burden of Disease Study 2017. Lancet Gastroenterol Hepatol. 2019;4(12):913\u201333.","journal-title":"Lancet Gastroenterol Hepatol"}],"container-title":["BMC Women's Health"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12905-021-01571-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12905-021-01571-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12905-021-01571-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,2,11]],"date-time":"2023-02-11T01:04:33Z","timestamp":1676077473000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcwomenshealth.biomedcentral.com\/articles\/10.1186\/s12905-021-01571-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,12,18]]},"references-count":49,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2021,12]]}},"alternative-id":["1571"],"URL":"https:\/\/doi.org\/10.1186\/s12905-021-01571-3","relation":{},"ISSN":["1472-6874"],"issn-type":[{"value":"1472-6874","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,12,18]]},"assertion":[{"value":"14 January 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 December 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 December 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study was reviewed and approved by Research Ethics Committee of Nantong University. The data we used were secondary data publicly released from the Global Health Data Exchange query did not require informed patient consent.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"419"}}